Jun 2, 2026Effective9999999995-26-001853
All companies
Start with eToro
[EFFECT] Brainstorm Cell Therapeutics Inc. SEC Filing | BCLI SEC Filing - Form EFFECT BrainStorm Cell Therapeutics Announces Publication Calling for Updated FDA Approaches to ALS, Rare Diseases and Regenerative Medicine
Brainstorm Cell Therapeutics Inc
BCLIIPO Upcoming
IPO UpcomingUnited States(OTC)0 markets
Official IPO
Filed· OTC· Listing market: United StatesExpected IPO date
To be announced
Final IPO price
To be announced
Shares offered
To be announced
IPO raise
To be announced
Sources: sec-harvest
No live market is quoted for Brainstorm Cell Therapeutics Inc yet. Get in line for IPO-day access through a broker in the meantime.
eToro
Invest in stocks once they list with eToro
Trade stocks, ETFs and crypto from one simple account.
Financials
UnprofitableFrom SEC filings, latest FY ending Dec 31, 2025 · CIK 0001137883.
Revenue
—
Net income
-$10.31M
Gross margin
—
Cash
$29K
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating income | -$9.95M | -$11.69M | -$21.44M | -$24.82M | -$24.54M |
| Net income | -$10.31M | -$11.62M | -$17.19M | -$24.28M | -$24.46M |
| R&D expense | $4.18M | $4.65M | $10.75M | $13.96M | $15.24M |
| Cash & equivalents | $29K | $187K | $1.3M | $772K | $18.86M |
| Total assets | $1.02M | $1.83M | $4.21M | $8.45M | $29.28M |
| Total liabilities | $11.01M | $9.6M | $9.07M | $11.47M | $9.94M |
| Shareholders' equity | -$9.99M | -$7.76M | -$4.86M | -$3.02M | $19.34M |
About Brainstorm Cell Therapeutics Inc
Brainstorm Cell Therapeutics Inc is a healthcare and life-sciences company with a business profile centered on medical products, therapies, diagnostics, or health-related services.
What the company does
- Develops healthcare products, therapies, devices, or services where clinical evidence and regulatory execution are central to the business.
- Operates in a market shaped by product differentiation, development timelines, reimbursement or customer adoption, and disciplined capital allocation.
- Relies on technical, clinical, commercial, and operational teams to move products from development toward broader use.
Business profile
Brainstorm Cell Therapeutics Inc belongs to the healthcare and life-sciences market, where product evidence, regulatory pathways, customer adoption, and funding discipline shape long-term outcomes.
SEC IPO filings
EffectiveEDGAR filings resolved from BCLI / CIK 0001137883.
S-1S-1
May 21, 2026Filed0001104659-26-064628
RWRW
Jul 22, 2025Withdrawn0001104659-25-069626
Sep 27, 2024Effective9999999995-24-002998
CORRESPfilename1.htm
Sep 26, 2024SEC correspondence0001104659-24-103101
CORRESPfilename1.htm
Sep 24, 2024SEC correspondence0001104659-24-102456
UPLOADfilename1.pdf
Sep 20, 2024SEC correspondence0000000000-24-010744
Sep 6, 2024Effective9999999995-24-002744
CORRESPfilename1.htm
Sep 4, 2024SEC correspondence0001104659-24-096870
UPLOADfilename1.pdf
Sep 3, 2024SEC correspondence0000000000-24-009978
Aug 19, 2021Effective9999999995-21-003250
CORRESPfilename1.htm
Aug 17, 2021SEC correspondence0001104659-21-106992
Latest Brainstorm Cell Therapeutics Inc IPO news
Recent sourced articles classified for IPO relevance, with platform-access noise filtered out where possible.
StockTitanJun 3, 2026IPO context
StockTitan reports an SEC Notice of Effectiveness for Brainstorm Cell Therapeutics’ Form S-1, with an effectiveness date of June 2, 2026 (5:00 P.M.), and shows the posting timestamp as 06/03/2026 12:15 AM.
PR NewswireJun 2, 2026IPO context
BrainStorm Cell Therapeutics said on June 2, 2026 that a publication called for updated FDA approaches to ALS, rare diseases, and regenerative medicine. The release frames the company’s scientific/regulatory positioning but does not announce a new IPO event.
Brainstorm Cell Therapeutics Inc IPO — frequently asked questions
- When is Brainstorm Cell Therapeutics Inc's IPO?
- Brainstorm Cell Therapeutics Inc has not announced an official IPO date yet — it is still privately held. We update this page as soon as an IPO date, filing or price range is reported.
- What is Brainstorm Cell Therapeutics Inc's expected IPO price?
- Brainstorm Cell Therapeutics Inc's IPO price has not been set yet. The price range is usually disclosed in the final prospectus, shortly before the company lists.
- Is Brainstorm Cell Therapeutics Inc publicly traded?
- Not yet — Brainstorm Cell Therapeutics Inc is still a private company, so its shares aren't available on public exchanges. IPO Tracker monitors pre-IPO markets, IPO filings and the IPO calendar, so Brainstorm Cell Therapeutics Inc's pre-IPO price and IPO date will appear here as soon as they're available.